Clinical features and prognoses of acute transverse myelitis in patients with systemic lupus erythematosus. Safety of the concomitant use of methotrexate and a prophylactic dose of trimethoprim-sulfamethoxazole. The risk of herpes zoster in patients with ankylosing spondylitis: Analysis of the Korean National Health Insurance Service - Sample cohort database. CD14(+) Cells with the Phenotype of Infiltrated Monocytes Consist of Distinct Populations Characterized by Anti-inflammatory as well as Pro-inflammatory Activity in Gouty Arthritis. Ileocolonoscopic findings in patients with ankylosing spondylitis: a single center retrospective study. Interleukin-32 Gamma Stimulates Bone Formation by Increasing miR-29a in Osteoblastic Cells and Prevents the Development of Osteoporosis. Longterm Outcomes of Renal Artery Involvement in Takayasu Arteritis. Nontuberculous mycobacterial infection in rheumatoid arthritis patients: a single-center experience in South Korea. Risk of Colchicine-Associated Myopathy in Gout: Influence of Concomitant Use of Statin. The Reply. Adequacy of initiating TNF antagonists within 3 weeks of starting latent tuberculosis infection treatment in patients with immune-mediated inflammatory diseases. Febuxostat in Hyperuricemic Patients With Advanced CKD. Late-onset IgA vasculitis in adult patients exhibits distinct clinical characteristics and outcomes. Neutrophil-to-lymphocyte ratio is a reliable marker of treatment response in rheumatoid arthritis patients during tocilizumab therapy. Safety of tumor necrosis factor inhibitor therapy in patients with a prior malignancy. Clinical outcomes of hydronephrosis in patients with systemic lupus erythematosus. Comparison of LTBI treatment regimens for patients receiving anti-tumour necrosis factor therapy. Factors related to outcomes in lupus-related protein-losing enteropathy High level of interleukin-32 gamma in the joint of ankylosing spondylitis is associated with osteoblast differentiation. Interleukin-33 acts as a transcriptional repressor and extracellular cytokine in fibroblast-like synoviocytes in patients with rheumatoid arthritis Mortality in patients with rheumatoid arthritis-associated interstitial lung disease treated with an anti-tumor necrosis factor agent. Assessment of peripheral neuropathy in patients with rheumatoid arthritis who complain of neurologic symptoms. Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay. Frequency of immunoglobulin G4-related aortitis in cases with aortic resection and their clinical characteristics compared to other aortitises. Lupus enteritis: clinical characteristics and predictive factors for recurrence. Mycobacterial diseases developed during anti-tumour necrosis factor-α therapy Neuro-beh?et's disease in South Korea: clinical characteristics and treatment response. Outcome of takayasu arteritis with inactive disease at diagnosis: the extent of vascular involvement as a predictor of activation.
Neuro-behcet’s disease in Korea: clinical characteristics and treatment response 류마티스 관절염 환자에서 발생한 치아돌기 비외상골절 REACTIVATION OF LATENT TUBERCULOSIS INFECTION AND NEW INFECTION OF TUBERCULOSIS IN PATIENTS WITH ANTI-TUMOR NECROSIS FACTOR THERAPY FOR TUBERCULOSIS-ENDEMIC AREA Why do some rheumatoid arthritis patients have high ESR levels despite clinical remission? Reactivation of Latent Tuberculosis infection and New infection of Tuberculosis in Patients with Anti-Tumor Necrosis Factor Therapy Sclerostin in plasma and synovial fluid inversely correlate with disease severity in knee osteoarthritis A Randomized Controlled Trial of The Efficacy of Incentive Spirometer Exercise on Pulmonary Functions of Patients with Ankylosing Spondylitis Stabilized by Tumor Necrosis Factor Inhibitor Therapy
TNF-α and IL-6 Inhibit Anti-osteoclastogenic Effect of Human CD4+CD25+ Regulatory T Cells In Vitro Inhibitory effects of melittin on the production of lipopolysaccaharideinduced matrixmetalloroteinase 3 in human rheumatoid arthritic fibroblast like synoviocytes Human CD4+ CD25 + Regulatory T Cells Inhibit the diffenrentiation of Osteoclasts from Peripheral Blood Mononuclear Cells in Vitro